What BioCircuit Technologies does

BioCircuit Technologies is a privately held medical device company headquartered in Atlanta, Georgia, that develops and commercializes devices for monitoring, controlling, and repairing peripheral nerves. The company was spun off from Axion Biosystems in June 2019 and currently employs 11–50 people. Its flagship product, Nerve Tape®, received FDA 510(k) clearance in July 2022 as the first sutureless nerve repair device on the U.S. market. The device combines a porcine small intestinal submucosa (SIS) biomaterial wrap with integrated Nitinol microhooks (penetration depth under 0.5mm) that attach to the outer sheath of severed nerves, enabling coaptation without microsutures. Clinical data demonstrates 4.8x faster repair times and 2.6x stronger repairs compared to microsuture, with 97% alignment success among surgeons and trainees. The second product, ConformaWrap®, launched in September 2025, is an SIS-based nerve protector for use in peripheral nerve injuries without gap. BioCircuit is also developing a Reflex Operant Conditioning (ROC) system in collaboration with MUSC and NCAN for spasticity management in spinal cord injury patients.

The company's go-to-market is an enterprise field sales motion targeting surgeons and hospitals in the United States, supplemented by direct email ordering, conference sales, and clinical education programs including the Breast Neurotization Visitation Program. BioCircuit generates revenue through one-time hardware sales of single-use surgical devices purchased by hospitals and surgical centers. Pricing is not publicly disclosed; orders are placed via email or through sales representatives. The company has secured approximately $9 million in Series Seed funding (September 2022, from Alsora Capital and GRA Venture Fund) plus approximately $6.6 million in NIH grant funding across three cycles (2021, 2023, 2024). Within 16 months of first human implants in June 2024, over 3,500 Nerve Tape devices had been implanted, earning the company a place on the 2025 Inc. 5000 list. Customer evidence spans leading academic medical centers including Weill Cornell Medicine, Mayo Clinic Arizona, RUSH University Medical Center, Beaumont Hospital, and UC Davis.

Name

BioCircuit Technologies

Legal name

BioCircuit Technologies, Inc.

Website

https://www.biocircuit.com/

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

BioCircuit Technologies develops and commercializes FDA-cleared peripheral nerve repair devices, including Nerve Tape (the first sutureless nerve coaptation connector) and ConformaWrap (an SIS nerve protector), serving plastic, reconstructive, hand, and head-and-neck surgeons at U.S. hospitals and surgical centers.

Ownership category

akta.pro rank

Product category

Peripheral Nerve Repair Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)

Keywords

• Peripheral nerve repair
• Sutureless nerve device
• Medical device manufacturing
• Neuromodulation systems
• Electrophysiology devices

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: BioCircuit generates revenue through the sale of medical devices including Nerve Tape and ConformaWrap. These are one-time use surgical devices purchased by hospitals and surgical centers for use in nerve repair procedures.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

BioCircuit Technologies develops and commercializes FDA-cleared medical devices for peripheral nerve repair and neuromodulation. Its flagship product, Nerve Tape, is the first FDA-cleared sutureless nerve repair device that combines porcine Small Intestinal Submucosa (SIS) biomaterial with integrated Nitinol microhooks to perform sutureless nerve coaptation. The company also offers ConformaWrap, a porcine SIS nerve protection wrap, and is developing a Reflex Operant Conditioning (ROC) system for spasticity management.

Product overview

BioCircuit Technologies offers a focused portfolio of two FDA-cleared medical devices for peripheral nerve repair: Nerve Tape® and ConformaWrap®. Nerve Tape® is the company's flagship product - the first FDA-cleared sutureless nerve repair device that uses flexible biomaterial with integrated Nitinol microhooks for quick, sutureless nerve coaptation. ConformaWrap® is a complementary SIS-based nerve wrap product that provides protective barrier coverage for nerve protection without requiring sutures. Together, these products address different aspects of nerve repair and protection, from direct coaptation (Nerve Tape) to protective wrapping (ConformaWrap).

Differentiator

Problem solved

Functional benefit

Brands

• Nerve Tape: The first FDA-cleared sutureless device for nerve repair. A sutureless connector that simplifies nerve repair with flexible biomaterial and integrated microscale hooks.
• ConformaWrap

Products and services

• Nerve Tape® The first FDA-cleared sutureless device for peripheral nerve repair. Nerve Tape combines a porcine Small Intestinal Submucosa (SIS) wrap with integrated Nitinol microhooks that securely attach to the outer sheath of severed nerves with penetration depth less than 0.5mm, providing a strong hold while distributing tension across the repair site. It eliminates the need for microsuturing, reducing repair time and minimizing tissue damage. Indicated for peripheral nerve repair procedures across plastic surgery, hand/orthopedic, oral/maxillofacial, head & neck, breast reconstruction, and lower extremity applications.
• ConformaWrap® A porcine Small Intestinal Submucosa (SIS) nerve protector wrap that provides surgeons with a customizable, easy-to-use solution for nerve protection. ConformaWrap may eliminate the need for suturing to reduce operative time and complexity, and is designed to prevent the nerve from reattaching to surrounding tissue and reduce the risk of post-surgical scarring. Indicated for management of peripheral nerve injuries where there is no gap.

Quantifiable outcome

• 4.8x faster repair time compared to microsuture (1.6 ± 0.8 min vs 7.2 ± 3.6 min)
• +5 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• MUSC (Medical University of South Carolina)coreStrategic or Co-development PartnerCollaborative partnership for development of the Reflex Operant Conditioning (ROC) system for spasticity management in spinal cord injury patients.
• NCAN (Neural Control of Human Movement)coreStrategic or Co-development PartnerCollaboration partner for ROC system development targeting spasticity management and neurorehabilitation research.
• Global Nerve FoundationcoreStrategic or Co-development PartnerPartnership with Global Nerve Foundation to advance nerve repair and improve patient outcomes through impactful, innovative projects. Joint webinars and educational programs.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Synapse Biomedical: Synapse Biomedical develops implanted neurostimulation systems (e.g., NeuRx for diaphragm stimulation) — an emerging neurostimulation peer relevant to BioCircuit's ROC platform targeting spasticity management.
• Polyganics: Polyganics develops bioresorbable nerve repair devices (e.g., NEUROLAC) for peripheral nerve gaps, representing a European emerging competitor with overlapping biomaterial-based nerve repair technology.
• Checkpoint Surgical: Checkpoint Surgical makes nerve stimulation and localization devices for intraoperative use — adjacent to BioCircuit's nerve repair focus and relevant to the same surgeon customers (hand, plastic, orthopedic surgeons).

Broad incumbents

• Medtronic: Medtronic operates a large neuromodulation franchise (spinal cord stimulators, deep brain stimulators, peripheral nerve stimulators) and competes broadly with BioCircuit's developing ROC neuromodulation platform.
• Abbott: Abbott's neuromodulation business (Proclaim DRG and SCS systems) makes it a broad incumbent in peripheral nerve and spinal cord stimulation, with potential overlap with BioCircuit's future ROC neuromodulation pipeline.
• Stryker: Stryker is a large diversified medical device company with surgical, orthopedic, and neurosurgery franchises. It competes in nerve repair and adjacent surgical consumables where BioCircuit sells Nerve Tape and ConformaWrap.
• Boston Scientific: Boston Scientific operates a sizeable neuromodulation franchise (WaveWriter, Vercise) addressing pain and movement disorders — a relevant broad incumbent against BioCircuit's pipeline neuromodulation efforts.
• Baxter International: Baxter offers a range of surgical and biosurgery products (including hemostats and sealants relevant to peripheral nerve procedures) — a broad incumbent competing in the surgical consumables category where BioCircuit sells its disposable devices.
• Integra LifeSciences: Integra offers NeuraGen nerve guide and other regenerative peripheral nerve repair products within a broad surgical and neurosurgery portfolio. It competes with BioCircuit in nerve repair while serving many other surgical specialties.

Direct peers

• Axogen: Axogen is the dominant player in peripheral nerve repair, offering Avance nerve grafts, AcroVal, and Connector-Assisted devices — the established incumbent against which BioCircuit's Nerve Tape competes directly for the same surgical nerve coaptation workflow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/wix
• YouTubeyoutube.com/@biocircuittechnologies
• Facebookfacebook.com/wix
• LinkedInlinkedin.com/company/biocircuit-technologies
• Instagraminstagram.com/nervetapeit

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds6 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioCircuit Technologies